AR and posterior cortical atrophy: PCa growth is dependent on ligand-associated AR signaling that renders them susceptible to therapies that target androgen signaling, such as androgen-deprivation therapy (ADT), which are widely used in the clinic to treat patients as first-line treatment for metastatic disease.